Flexion Therapeutics to Present at the ICR | Westwicke Investment Conference
January 07 2021 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the ICR | Westwicke
Investment Conference. The virtual fireside chat is scheduled
to begin at 10:45 a.m. ET on Thursday, January 14, 2021.
To access the live webcast of the presentation, please visit the
Flexion website at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The Company's
core values are focus, ingenuity, tenacity, transparency and fun.
Please visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024